Recognizing Alopecia Areata: Pathophysiology, Medical Impact, and Epidemiological Trends

Welcome back to another AJMC Insights series. In this episode titled, 'Recognizing Alopecia Areata: Pathophysiology, Medical Impact, and Epidemiological Trends', Dr. Amy McMichael led the conversation about the following questions:

What are the signs, symptoms, and underlying pathophysiology of alopecia areata (AA)?

Why is it important to view this as a medical disease rather than a cosmetic issue?

What is the epidemiology of alopecia areata and how are you predicting the prevalence to trend in the future?

Dr. Amy McMichael highlighted the clinical presentation of alopecia areata, describing the characteristic patchy, round hair loss that can progress to more extensive forms including ophiasis, alopecia totalis, and alopecia universalis, with associated symptoms such as burning, stinging, conjunctivitis, and worsening allergic reactions from loss of eyelash and nasal hairs. Dr. McMichael emphasized the importance of viewing alopecia areata as a medical rather than cosmetic condition, given its frequent association with other autoimmune diseases — including vitiligo, rheumatoid arthritis, and multiple sclerosis — as well as its profound psychosocial impact on quality of life, particularly in children and women. Turning to epidemiology, she noted that while alopecia areata was historically considered a disease primarily affecting Caucasian patients equally across sexes, larger population-based studies using electronic medical record data have revealed a higher prevalence in women and a significant burden among patients with skin of color, including African American, Asian, and Hispanic populations. She also highlighted that the availability of three FDA-approved treatments is now drawing more patients to seek care, thereby expanding the epidemiological data and reinforcing that alopecia areata affects patients of all ethnicities and races, typically presenting in teens through the mid-30s.

Throughout the conversation, the expert provided a comprehensive reflection on the field and the factors that may shape how clinicians approach care moving forward.

In the next episode, 'Diagnosing Alopecia Areata: Differential Diagnosis, Comorbidities, and Disease Burden,' the panelist continues their discussion on alopecia areata and highlight the clinical, economic, and psychosocial burden patients may experience, how a definitive diagnosis is made, and the range of comorbidities that commonly accompany the disease.